Symbols / MCTA Stock $29.36 +0.00% Charming Medical Limited
MCTA (Stock) Chart
About
Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. Its services includes womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding. The company also provides TCM-inspired supplements products, which includes Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets; and beauty products, including ginseng soothing anti-allergy moisturizing wash for skin issues, and scalp health. In addition, it offers consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions. Further, the company's products are used for the treatment of alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women's health issues. it operates wellness centres. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.
Stock Fundamentals
Scroll to Statements| Market Cap | 504.26M | Enterprise Value | 448.13M | Income | 657.29K | Sales | 5.42M | Book/sh | 0.02 | Cash/sh | 0.17 |
| Dividend Yield | — | Payout | 0.00% | Employees | 49 | IPO | — | P/E | 419.36 | Forward P/E | — |
| PEG | — | P/S | 92.98 | P/B | 1276.30 | P/C | — | EV/EBITDA | 388.40 | EV/Sales | 82.63 |
| Quick Ratio | 0.57 | Current Ratio | 0.59 | Debt/Eq | 160.17 | LT Debt/Eq | — | EPS (ttm) | 0.07 | EPS next Y | — |
| EPS Growth | — | Revenue Growth | -27.00% | Earnings | — | ROA | 10.64% | ROE | — | ROIC | — |
| Gross Margin | 96.02% | Oper. Margin | -0.94% | Profit Margin | 12.12% | Shs Outstand | 15.18M | Shs Float | 4.31M | Short Float | 14.39% |
| Short Ratio | — | Short Interest | — | 52W High | 31.70 | 52W Low | 4.30 | Beta | — | Avg Volume | 0.00 |
| Volume | 0.00 | Target Price | — | Recom | None | Prev Close | $29.36 | Price | $29.36 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$29.36
Latest analyst target
3. DCF / Fair value
$0.86
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$29.36
Low
—
High
—
Mean
—
- symbol__ Stock Quote Price and Forecast - CNN ue, 21 Oct 2025 16
- Investors who lost money with Charming Medical Limited (NASDAQ: MCTA) should contact the Shareholders Foundation in connection with Lawsuit - Morningstar ue, 03 Feb 2026 08
- MCTA SEC Filings - Charming Medical 10-K, 10-Q, 8-K Forms - Stock Titan Sat, 28 Mar 2026 13
- Shareholders who lost money in shares Charming Medical Ltd. (NASDAQ: MCTA) Should Contact Wolf Haldenstein Immediately - PR Newswire Wed, 07 Jan 2026 08
- 2,000,000 Class B Ordinary Shares of Charming Medical Limited are subject to a Lock-Up Agreement Ending on 21-APR-2026. - marketscreener.com ue, 21 Apr 2026 00
- Charming Medical prices IPO at $4 per share for NASDAQ listing - Investing.com ue, 21 Oct 2025 07
- Charming Medical Limited Announces Closing of Initial Public Offering - Yahoo Finance Wed, 22 Oct 2025 07
- Charming Medical (MCTA) CEO reports Class A and B share stakes - Stock Titan Fri, 27 Mar 2026 07
- MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm - Morningstar Mon, 16 Feb 2026 08
- Nasdaq halts trading of Charming Medical after SEC suspension - Investing.com Wed, 26 Nov 2025 08
- Charming Medical Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq - Yahoo Finance ue, 21 Oct 2025 07
- Investor Notice: Robbins LLP Informs Investors of the Charming Medical, Limited Securities Class Action - PR Newswire Fri, 19 Dec 2025 08
- Latest MCTA News - Charming Medical Limited Announces Full Exe... - Stock Titan ue, 28 Oct 2025 07
- CHARMING MEDICAL CLASS ACTION DEADLINE: Bragar Eagel & - GlobeNewswire Fri, 06 Feb 2026 08
- Charming Medical Faces Trading Suspension Amid SEC Investigation - TipRanks hu, 13 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue |
|
6.22
+3.43%
|
6.02
+70.37%
|
3.53
|
| Operating Revenue |
|
6.22
+3.43%
|
6.02
+70.37%
|
3.53
|
| Cost Of Revenue |
|
2.04
-2.86%
|
2.10
+3.16%
|
2.04
|
| Reconciled Cost Of Revenue |
|
2.04
-2.86%
|
2.10
+3.16%
|
2.04
|
| Gross Profit |
|
4.18
+6.81%
|
3.91
+162.00%
|
1.49
|
| Operating Expense |
|
2.57
-6.38%
|
2.74
+53.82%
|
1.78
|
| Selling General And Administration |
|
2.32
-1.38%
|
2.35
+41.39%
|
1.66
|
| Selling And Marketing Expense |
|
1.00
+16.28%
|
0.86
+29.27%
|
0.66
|
| General And Administrative Expense |
|
1.32
-11.56%
|
1.49
+49.48%
|
1.00
|
| Other Gand A |
|
0.61
-5.51%
|
0.64
+83.65%
|
0.35
|
| Other Operating Expenses |
|
-0.02
-1007.73%
|
-0.00
+98.47%
|
-0.09
|
| Total Expenses |
|
4.61
-4.85%
|
4.84
+26.79%
|
3.82
|
| Operating Income |
|
1.62
+37.58%
|
1.17
+508.34%
|
-0.29
|
| Total Operating Income As Reported |
|
1.39
+37.68%
|
1.01
+293.51%
|
-0.52
|
| EBITDA |
|
1.72
+20.98%
|
1.42
+851.46%
|
-0.19
|
| Normalized EBITDA |
|
1.72
+20.80%
|
1.42
+851.46%
|
-0.19
|
| Reconciled Depreciation |
|
0.26
-32.74%
|
0.39
+85.57%
|
0.21
|
| EBIT |
|
1.46
+41.43%
|
1.03
+357.25%
|
-0.40
|
| Total Unusual Items |
|
0.00
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
0.00
|
—
|
—
|
| Net Income |
|
1.20
+54.16%
|
0.78
+354.92%
|
-0.31
|
| Pretax Income |
|
1.44
+43.02%
|
1.00
+338.66%
|
-0.42
|
| Net Non Operating Interest Income Expense |
|
-0.17
+1.66%
|
-0.17
-11.80%
|
-0.15
|
| Interest Expense Non Operating |
|
0.02
-19.87%
|
0.03
+28.59%
|
0.02
|
| Net Interest Income |
|
-0.17
+1.66%
|
-0.17
-11.80%
|
-0.15
|
| Interest Expense |
|
0.02
-19.87%
|
0.03
+28.59%
|
0.02
|
| Interest Income Non Operating |
|
0.06
+228.68%
|
0.02
+89.67%
|
0.01
|
| Interest Income |
|
0.06
+228.68%
|
0.02
+89.67%
|
0.01
|
| Other Income Expense |
|
-0.01
-5750.00%
|
-0.00
-101.11%
|
0.02
|
| Other Non Operating Income Expenses |
|
-0.02
-6974.77%
|
-0.00
-101.11%
|
0.02
|
| Gain On Sale Of Security |
|
0.00
|
—
|
—
|
| Tax Provision |
|
0.24
+29.89%
|
0.18
+314.17%
|
-0.08
|
| Tax Rate For Calcs |
|
0.00
-9.39%
|
0.00
-10.40%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
1.20
+45.92%
|
0.82
+344.85%
|
-0.34
|
| Net Income From Continuing Operation Net Minority Interest |
|
1.20
+54.16%
|
0.78
+354.92%
|
-0.31
|
| Net Income From Continuing And Discontinued Operation |
|
1.20
+54.16%
|
0.78
+354.92%
|
-0.31
|
| Net Income Continuous Operations |
|
1.20
+45.92%
|
0.82
+344.85%
|
-0.34
|
| Minority Interests |
|
0.00
+100.00%
|
-0.04
-244.10%
|
0.03
|
| Normalized Income |
|
1.20
+53.88%
|
0.78
+354.92%
|
-0.31
|
| Net Income Common Stockholders |
|
1.20
+54.16%
|
0.78
+354.92%
|
-0.31
|
| Diluted EPS |
|
—
|
0.05
+354.92%
|
-0.02
|
| Basic EPS |
|
—
|
0.05
+354.92%
|
-0.02
|
| Basic Average Shares |
|
—
|
16.94
+0.00%
|
16.94
|
| Diluted Average Shares |
|
—
|
16.94
+0.00%
|
16.94
|
| Diluted NI Availto Com Stockholders |
|
1.20
+54.16%
|
0.78
+354.92%
|
-0.31
|
| Depreciation Amortization Depletion Income Statement |
|
0.26
-32.74%
|
0.39
+85.57%
|
0.21
|
| Depreciation And Amortization In Income Statement |
|
0.26
-32.74%
|
0.39
+85.57%
|
0.21
|
| Depreciation Income Statement |
|
0.26
-32.74%
|
0.39
+85.57%
|
0.21
|
| Rent And Landing Fees |
|
0.71
-16.14%
|
0.85
+31.05%
|
0.65
|
| Rent Expense Supplemental |
|
0.71
-16.14%
|
0.85
+31.05%
|
0.65
|
| Total Other Finance Cost |
|
0.21
+28.70%
|
0.16
+15.04%
|
0.14
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets |
|
5.36
+9.71%
|
4.88
-23.53%
|
6.38
|
| Current Assets |
|
3.37
-8.19%
|
3.67
-10.98%
|
4.12
|
| Cash Cash Equivalents And Short Term Investments |
|
2.76
+31.26%
|
2.10
+9.04%
|
1.93
|
| Cash And Cash Equivalents |
|
0.82
-61.17%
|
2.10
+9.04%
|
1.93
|
| Cash Financial |
|
—
|
2.10
+9.04%
|
1.93
|
| Other Short Term Investments |
|
1.94
|
0.00
|
—
|
| Receivables |
|
0.58
-62.29%
|
1.54
-27.71%
|
2.12
|
| Accounts Receivable |
|
0.40
+12.60%
|
0.35
+88.39%
|
0.19
|
| Gross Accounts Receivable |
|
0.40
+12.60%
|
0.35
+88.39%
|
0.19
|
| Allowance For Doubtful Accounts Receivable |
|
0.00
|
0.00
|
0.00
|
| Other Receivables |
|
0.18
-38.72%
|
0.30
+148.02%
|
0.12
|
| Inventory |
|
0.03
-4.81%
|
0.03
-57.56%
|
0.07
|
| Total Non Current Assets |
|
1.99
+63.74%
|
1.21
-46.37%
|
2.26
|
| Net PPE |
|
1.21
+31.32%
|
0.92
-48.72%
|
1.80
|
| Gross PPE |
|
3.21
+28.00%
|
2.51
-14.10%
|
2.92
|
| Accumulated Depreciation |
|
-2.00
-26.08%
|
-1.59
-41.29%
|
-1.12
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
1.83
+36.27%
|
1.34
-31.80%
|
1.97
|
| Machinery Furniture Equipment |
|
0.66
+78.59%
|
0.37
+82.89%
|
0.20
|
| Leases |
|
0.72
-9.28%
|
0.80
+6.13%
|
0.75
|
| Non Current Deferred Assets |
|
0.65
+172.99%
|
0.24
-12.76%
|
0.27
|
| Non Current Deferred Taxes Assets |
|
0.08
-63.39%
|
0.21
-22.59%
|
0.27
|
| Non Current Prepaid Assets |
|
0.13
+134.95%
|
0.05
-71.82%
|
0.19
|
| Total Liabilities Net Minority Interest |
|
5.31
-11.97%
|
6.03
-21.23%
|
7.65
|
| Current Liabilities |
|
4.95
-15.84%
|
5.88
-17.98%
|
7.17
|
| Payables And Accrued Expenses |
|
0.68
+19.64%
|
0.57
+136.80%
|
0.24
|
| Payables |
|
0.48
+198.96%
|
0.16
+1144.02%
|
0.01
|
| Accounts Payable |
|
0.00
|
0.00
-100.00%
|
0.00
|
| Other Payable |
|
0.04
-8.26%
|
0.04
+256.23%
|
0.01
|
| Current Accrued Expenses |
|
0.21
-49.83%
|
0.41
+80.27%
|
0.23
|
| Total Tax Payable |
|
0.22
+85.60%
|
0.12
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.80
-1.29%
|
0.81
-38.64%
|
1.33
|
| Current Debt |
|
0.31
-29.01%
|
0.44
-24.94%
|
0.59
|
| Current Capital Lease Obligation |
|
0.49
+31.81%
|
0.37
-49.63%
|
0.74
|
| Current Deferred Liabilities |
|
3.46
-22.97%
|
4.50
-19.75%
|
5.60
|
| Current Deferred Revenue |
|
3.46
-22.97%
|
4.50
-19.75%
|
5.60
|
| Total Non Current Liabilities Net Minority Interest |
|
0.36
+141.51%
|
0.15
-69.39%
|
0.48
|
| Long Term Debt And Capital Lease Obligation |
|
0.36
+141.51%
|
0.15
-69.39%
|
0.48
|
| Long Term Capital Lease Obligation |
|
0.36
+141.51%
|
0.15
-69.39%
|
0.48
|
| Stockholders Equity |
|
0.05
+104.56%
|
-1.08
+6.83%
|
-1.16
|
| Common Stock Equity |
|
0.05
+104.56%
|
-1.08
+6.83%
|
-1.16
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
16.94
+0.00%
|
16.94
+0.00%
|
16.94
|
| Ordinary Shares Number |
|
16.94
+0.00%
|
16.94
+0.00%
|
16.94
|
| Additional Paid In Capital |
|
0.31
-17.56%
|
0.38
+0.00%
|
0.38
|
| Retained Earnings |
|
0.12
+111.06%
|
-1.08
+7.13%
|
-1.16
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.00
-1840.98%
|
0.00
-94.77%
|
0.00
|
| Minority Interest |
|
0.00
+100.00%
|
-0.07
+39.55%
|
-0.11
|
| Other Equity Adjustments |
|
-0.00
-1840.98%
|
0.00
-94.77%
|
0.00
|
| Total Equity Gross Minority Interest |
|
0.05
+104.30%
|
-1.15
+9.67%
|
-1.27
|
| Total Capitalization |
|
0.05
+104.56%
|
-1.08
+6.83%
|
-1.16
|
| Working Capital |
|
-1.58
+28.52%
|
-2.21
+27.44%
|
-3.05
|
| Invested Capital |
|
0.36
+157.07%
|
-0.64
-11.93%
|
-0.57
|
| Total Debt |
|
1.16
+20.73%
|
0.96
-46.87%
|
1.81
|
| Capital Lease Obligations |
|
0.85
+63.16%
|
0.52
-57.47%
|
1.22
|
| Net Tangible Assets |
|
0.05
+104.56%
|
-1.08
+6.83%
|
-1.16
|
| Tangible Book Value |
|
0.05
+104.56%
|
-1.08
+6.83%
|
-1.16
|
| Duefrom Related Parties Current |
|
0.00
-100.00%
|
0.89
-51.30%
|
1.82
|
| Dueto Related Parties Current |
|
0.21
|
0.00
|
—
|
| Line Of Credit |
|
0.31
-29.01%
|
0.44
-24.94%
|
0.59
|
| Other Equity Interest |
|
-0.38
+0.00%
|
-0.38
+0.00%
|
-0.38
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
0.43
+44.16%
|
0.30
-87.86%
|
2.43
|
| Cash Flow From Continuing Operating Activities |
|
0.43
+44.16%
|
0.30
-87.86%
|
2.43
|
| Net Income From Continuing Operations |
|
1.20
+45.92%
|
0.82
+344.85%
|
-0.34
|
| Depreciation Amortization Depletion |
|
0.26
-32.74%
|
0.39
+85.57%
|
0.21
|
| Depreciation |
|
0.26
-32.74%
|
0.39
+85.57%
|
0.21
|
| Depreciation And Amortization |
|
0.26
-32.74%
|
0.39
+85.57%
|
0.21
|
| Other Non Cash Items |
|
-0.01
+77.93%
|
-0.04
-161.49%
|
0.06
|
| Deferred Tax |
|
0.13
+115.88%
|
0.06
|
—
|
| Deferred Income Tax |
|
0.13
+115.88%
|
0.06
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
-0.00
|
0.00
|
—
|
| Change In Working Capital |
|
-1.16
-23.07%
|
-0.94
-137.76%
|
2.50
|
| Change In Receivables |
|
-0.04
+73.16%
|
-0.16
-7.11%
|
-0.15
|
| Changes In Account Receivables |
|
-0.04
+73.16%
|
-0.16
-7.11%
|
-0.15
|
| Change In Inventory |
|
0.00
-96.45%
|
0.04
+168.34%
|
-0.06
|
| Change In Prepaid Assets |
|
0.04
+207.15%
|
-0.04
+65.51%
|
-0.11
|
| Change In Payables And Accrued Expense |
|
-0.10
-131.14%
|
0.33
+82.66%
|
0.18
|
| Change In Payable |
|
-0.10
-131.14%
|
0.33
+82.66%
|
0.18
|
| Change In Account Payable |
|
-0.20
-197.34%
|
0.21
+16.56%
|
0.18
|
| Change In Other Working Capital |
|
-1.06
+4.46%
|
-1.11
-141.90%
|
2.64
|
| Investing Cash Flow |
|
-2.23
-958.63%
|
-0.21
+65.26%
|
-0.61
|
| Cash Flow From Continuing Investing Activities |
|
-2.23
-958.63%
|
-0.21
+65.26%
|
-0.61
|
| Net PPE Purchase And Sale |
|
-0.29
-36.53%
|
-0.21
+65.26%
|
-0.61
|
| Purchase Of PPE |
|
-0.29
-36.53%
|
-0.21
+65.26%
|
-0.61
|
| Capital Expenditure |
|
-0.29
-36.53%
|
-0.21
+65.26%
|
-0.61
|
| Net Investment Purchase And Sale |
|
-1.94
|
0.00
|
—
|
| Purchase Of Investment |
|
-1.94
|
0.00
|
—
|
| Financing Cash Flow |
|
0.52
+420.55%
|
0.10
+107.00%
|
-1.43
|
| Cash Flow From Continuing Financing Activities |
|
0.52
+420.55%
|
0.10
+107.00%
|
-1.43
|
| Net Issuance Payments Of Debt |
|
0.05
+142.23%
|
-0.12
+34.89%
|
-0.18
|
| Issuance Of Debt |
|
0.21
+436.93%
|
0.04
|
0.00
|
| Repayment Of Debt |
|
-0.16
-1.78%
|
-0.15
+13.34%
|
-0.18
|
| Long Term Debt Issuance |
|
0.21
+436.93%
|
0.04
|
0.00
|
| Long Term Debt Payments |
|
-0.03
-392.45%
|
-0.01
|
0.00
|
| Net Long Term Debt Issuance |
|
0.18
+444.09%
|
0.03
|
0.00
|
| Short Term Debt Payments |
|
-0.13
+12.16%
|
-0.15
+16.32%
|
-0.18
|
| Net Short Term Debt Issuance |
|
-0.13
+12.16%
|
-0.15
+16.32%
|
-0.18
|
| Net Other Financing Charges |
|
0.47
+118.70%
|
0.22
+117.25%
|
-1.25
|
| Changes In Cash |
|
-1.28
-793.21%
|
0.18
-53.45%
|
0.40
|
| Effect Of Exchange Rate Changes |
|
-0.00
+56.08%
|
-0.01
-285.84%
|
0.01
|
| Beginning Cash Position |
|
2.10
+9.04%
|
1.93
+26.40%
|
1.53
|
| End Cash Position |
|
0.82
-61.17%
|
2.10
+9.04%
|
1.93
|
| Free Cash Flow |
|
0.14
+63.10%
|
0.08
-95.36%
|
1.83
|
| Interest Paid Supplemental Data |
|
0.02
-19.87%
|
0.03
+28.59%
|
0.02
|
| Change In Income Tax Payable |
|
0.10
-14.40%
|
0.12
|
0.00
|
| Change In Tax Payable |
|
0.10
-14.40%
|
0.12
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|